Related Experiment Video
Updated: Jul 3, 2025
03:22
Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
Published on: March 1, 2024
435
Pneumocystis jirovecii pneumonia: a case report
1Internal Medicine Program, University of Connecticut, Farmington, CT, USA. gri@uchc.edu.
Journal of Medical Case Reports
|February 11, 2024
Summary
Pneumocystis jirovecii pneumonia (PJP) can be fatal if not diagnosed early, especially in patients without obvious risk factors. This case highlights diagnostic challenges and the critical need for timely PJP-targeted therapy in severe pneumonia.
Area of Science:
- Medical Case Study
- Infectious Diseases
- Pulmonology
Background:
- Pneumocystis jirovecii pneumonia (PJP) is a severe, life-threatening infection primarily affecting immunocompromised individuals, often associated with Human Immunodeficiency Virus (HIV).
- Early recognition and treatment of PJP are crucial for patient survival, yet diagnosis can be challenging, particularly in patients lacking apparent risk factors for immunosuppression.
Related Concept Videos
01:30Pneumonia I: Introduction
238
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
238
01:29Pneumonia II: Pathophysiology
272
The pathophysiology of pneumonia involves the following steps:
272
01:30Pneumonia III: Complications and Assessment
219
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
219
01:28Pneumonia IV: Management
327
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
327
01:30Pneumonia V: Nursing management and Prevention
2.1K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.1K
01:21Acute Respiratory Failure-II
234
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
234